Abstract
The use of nanoemulsions as a carrier system for skin targeting has attracted increased attention over recent years. Nanoemulsions can be intended for both topical and systemic delivery of the biologically active agents for controlled and targeted delivery. Nanoemulsion droplets fall within the size range of 20-200nm, typically below 100nm. Nanoemulsions have high surface area and ability to solubilize poorly soluble drugs. They are reported to have higher skin permeation and retention potential than other novel drug delivery systems like nanoparticles, liposomes, microemulsions etc. Use of nanoemulsions for skin targeting of drug is a current research scenario in the field of Pharmaceutics. This research area has generated immense interest from the Pharmaceutical industry and a number of nanoemulsion based cosmetics formulations like anti-aging creams, skin cleansing lotions etc. are available in the market. Recently, Zydus Cadilla launched the Oxalgin NanoGel™ diclofenac sodium nanoemulsion gel showing the importance of nanoemulsion as carrier system for skin targeting of drugs. This review embodies an in-depth discussion on composition, application, its mechanism of skin permeation and commercial aspects of nanoemulsions for skin targeting.
Keywords: Anti-acne, skin targeting, nanoemulsion, NSAIDs, commercial products, anti-fungal, anti-cancer, TOPICAL DELIVERY, Anti-Cancer Drugs
Drug Delivery Letters
Title: Nanoemulsions for Skin Targeting: Present Status and Future Prospects
Volume: 1 Issue: 2
Author(s): Mukta Singh and Subheet Jain
Affiliation:
Keywords: Anti-acne, skin targeting, nanoemulsion, NSAIDs, commercial products, anti-fungal, anti-cancer, TOPICAL DELIVERY, Anti-Cancer Drugs
Abstract: The use of nanoemulsions as a carrier system for skin targeting has attracted increased attention over recent years. Nanoemulsions can be intended for both topical and systemic delivery of the biologically active agents for controlled and targeted delivery. Nanoemulsion droplets fall within the size range of 20-200nm, typically below 100nm. Nanoemulsions have high surface area and ability to solubilize poorly soluble drugs. They are reported to have higher skin permeation and retention potential than other novel drug delivery systems like nanoparticles, liposomes, microemulsions etc. Use of nanoemulsions for skin targeting of drug is a current research scenario in the field of Pharmaceutics. This research area has generated immense interest from the Pharmaceutical industry and a number of nanoemulsion based cosmetics formulations like anti-aging creams, skin cleansing lotions etc. are available in the market. Recently, Zydus Cadilla launched the Oxalgin NanoGel™ diclofenac sodium nanoemulsion gel showing the importance of nanoemulsion as carrier system for skin targeting of drugs. This review embodies an in-depth discussion on composition, application, its mechanism of skin permeation and commercial aspects of nanoemulsions for skin targeting.
Export Options
About this article
Cite this article as:
Singh Mukta and Jain Subheet, Nanoemulsions for Skin Targeting: Present Status and Future Prospects, Drug Delivery Letters 2011; 1 (2) . https://dx.doi.org/10.2174/2210304x11101020159
DOI https://dx.doi.org/10.2174/2210304x11101020159 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transition Metal-Based Prodrugs for Anticancer Drug Delivery
Current Medicinal Chemistry Flavonoids: The Innocuous Agents Offering Protection against Alzheimer’s Disease Through Modulation of Proinflammatory and Apoptotic Pathways
Current Topics in Medicinal Chemistry Morpho-Functional Features of In-Vitro Cell Death Induced by Physical Agents
Current Pharmaceutical Design Nanotechnology and Alzheimer's Disease: What has been Done and What to Do'
Current Medicinal Chemistry Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review
Current Drug Targets Identification of Disease-Relevant Genes for Molecularly-Targeted Drug Discovery
Current Cancer Drug Targets Ubiquitylation and Cancer Development
Current Cancer Drug Targets Targeting STAT1 in Both Cancer and Insulin Resistance Diseases
Current Protein & Peptide Science Targeting Prostate Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response
Current Cancer Drug Targets Arsenic Immunotoxicity and Immunomodulation by Phytochemicals: Potential Relations to Develop Chemopreventive Approaches
Recent Patents on Inflammation & Allergy Drug Discovery The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)
Current Medicinal Chemistry C-KIT Signaling in Cancer Treatment
Current Pharmaceutical Design Cinnamic Acid Derivatives Induce Cell Cycle Arrest in Carcinoma Cell Lines
Medicinal Chemistry Breast Cancer in the Personal Genomics Era
Current Genomics 2-Aminoimidazole, Glycociamidine and 2-Thiohydantoin-Marine Alkaloids as Molecular Inspirations for the Development of Lead Structures
Current Drug Targets Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Current Drug Targets Acronycine Derivatives: A Promising Series of Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Mini-Reviews in Medicinal Chemistry Sphingolipid Metabolism Enzymes as Targets for Anti-Cancer Therapy
Current Drug Targets